Articles on Patent law

Displaying 21 - 40 of 40 articles

Novartis sought to charge A$26,000 a year for its anti-cancer drug, compared with A$2,000 per year for a generic copy. ChrisGoldNY

India’s Novartis patent ruling puts health before profits

Swiss pharmaceutical company Novartis this week lost a seven-year legal battle over a drug patent in India. It’s certainly a win for those in India who use the drug, and for patients in India more generally…
“It seems patent trolls are here to stay, but that might not be the case for much longer.” K.G.Hawes

Podcasts are patented – or so say the patent trolls

Can podcasting be patented? If you are an instigator of what’s being referred to as the SHIELD Act – introduced into US Congress last month – the answer would seem to be no. If you represent a US company…
As the Indian delegate said, ‘If we don’t get cheap technology we will never be able to adapt to climate change’. But Doha was reluctant to discuss the matter. Danish Wind Industry Association.

The Doha deadlock: intellectual property and climate change

In November 2001, Doha hosted trade talks over intellectual property and public health. The discussions resulted in the landmark Doha Declaration on the TRIPS Agreement and Public Health. The Doha Declaration…
The government has launched several inquiries into patent law and pharmaceutical drugs. Daniel Weir

Julia Gillard, Big Pharma, patent law and public health

It takes a lot of bravery for governments to stand up to big business. But the Gillard government has shown a lot of guts during its tenure. It stood up to Big Tobacco in the battle over plain packaging…
Pharmaceutical companies view the growing middle class in India and other emerging economies as a significant source of revenue. Ryan/Flickr

David and Goliath: Novartis challenges India’s patent law

India is the global focal point for legal and political struggles over patent rights and access to medicines. Particular attention is focused on the Swiss pharmaceutical giant Novartis, which is in battle…
Biotech patents are worth big money, so companies would fiercely resist a compulsory licence. sam d

Is it time to unlock biotech patents?

We’re in for another round of the biotech patent wars, with announcement the Productivity Commission will inquire into the compulsory licensing of patents. If adopted, compulsory licensing could increase…
Rio+20 has backtracked on many intellectual property measures put in place by Agenda 21. David Foote/AAP

Rio+20: who owns the Green Economy?

The Rio+20 summit has raised a number of difficult questions about law and technology: what is the relationship between intellectual property and the environment? What role does intellectual property play…
The SPICE balloon has been grounded. SPICE Project

Geoengineering trial cancelled: more regulation needed

Inventors have long been protecting their ideas by filing patent applications on new technologies. But is it appropriate for researchers or companies to own the intellectual property rights to climate-altering…
Leaders of the member states of the Trans-Pacific Strategic Economic Partnership Agreement (TPP) from 2010. Gobierno de Chile/Wikimedia Commons

A mercurial treaty: the Trans-Pacific Partnership and the United States

According to the United States Trade Representative (USTR), Ron Kirk, the Trans-Pacific Partnership is “an ambitious, next-generation, Asia-Pacific trade agreement that reflects U.S. priorities and values…
Drug prices reduce dramatically when large multinationals’ monopoly is broken. m.p.3./Flickr

Big Pharma in legal battles for monopoly prices in India

Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…
Synthetic biology may help us create artificial life, but how should we patent it? Wellcome Images

Inventing life: patent law and synthetic biology

With promises of improved medical treatments, greener energy and even artificial life, the field of synthetic biology has captured the public imagination and attracted significant government and commercial…
US-China competition could lead to a brighter clean energy future, or a trade war. whitehouse.gov

Who owns the sun? Patent law and clean energy

There is a trade war brewing between the United States and China over intellectual property relating to clean technologies – particularly solar power. Steven Chu, a scientist, Nobel Laureate in Physics…
How can we best reward creators and those who benefit from their creations? 917press

IP, patents, copyright, you

IDEAS AND OWNERSHIP: The concept of protecting ideas and innovation by legal means dates back to antiquity. But in the age of the internet and multinational business models, many of the existing laws are…
Software patenting was a fringe activity for the first 20 years of the software industry. opensourceway

Do patents create software innovation? Computer says no

What would the software industry look like without patents? It’s a question worth asking in the context of Apple’s recent body blow to Samsung, which will see Samsung’s Galaxy Tab 10.1 kept off Australian…
Feeding the world’s poor may not really be the main concern of companies that take out gene patents on crops. AAP

Is patenting crops really about feeding the hungry? A response

Michael Gilbert’s article starts with a title that poses a question - Will patenting crops help feed the hungry? Fair enough, except he then proceeds to provide an answer, which as the posted comments…
It can be hard to know where the next bit of hypercharged rhetoric will come from. fotoforlizzie

Patent wars … we get the war, but what about the patents?

If you believe the hype, the “patent wars” are well and truly underway. Google announced last week it will buy Motorola Mobility to get access to 15,000 of the handset manufacturer’s patents and HTC, Apple…
Federal governments should fund pharmaceutical research and development. AAP

Patent controversy: it’s time Big Pharma took its medicine

Over the last couple of decades, the pharmaceutical industry has come under attack for its perceived shortcomings amid claims that it’s greedy, profiteering nature has caused significant harm. However…

Top contributors

More